Show simple item record

dc.contributor.authorFerner, Robin
dc.contributor.authorAronson, Jeffrey K
dc.date.accessioned2023-06-28T12:24:59Z
dc.date.available2023-06-28T12:24:59Z
dc.date.issued2022-09-23
dc.identifier.citationFerner RE, Aronson JK. Medicines legislation and regulation in the United Kingdom 1500-2020. Br J Clin Pharmacol. 2023 Jan;89(1):80-92. doi: 10.1111/bcp.15497en_US
dc.identifier.eissn1365-2125
dc.identifier.doi10.1111/bcp.15497
dc.identifier.pmid35976677
dc.identifier.urihttp://hdl.handle.net/20.500.14200/1119
dc.description.abstractThe initial purposes of regulation of medicines in England, and latterly in the United Kingdom, were principally to raise government revenue, to discourage murder by poisoning and to regulate the activities of pharmacists. It was only much later that regulators sought to ensure that medicines were of good quality, reasonably safe, and at least somewhat effective, and to curtail misuse of drugs. Here we survey the history of the regulation of medicines and poisons in England from the perspective of clinicians with an interest in therapeutics.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectClinical pathologyen_US
dc.titleMedicines legislation and regulation in the United Kingdom 1500-2020.en_US
dc.typeArticle
dc.source.journaltitleBritish Journal of Clinical Pharmacology
rioxxterms.versionNAen_US
dc.contributor.trustauthorFerner, Robin
dc.contributor.departmentWest Midlands Centre for Adverse Drug Reactionsen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationUniversity of Birmingham; Sandwell and West Birmingham NHS Trust; University of Oxforden_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record